ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

What You Should Know About Cystic Fibrosis

Updated on November 30, 2017
Patrick Patrick profile image

Patrick has been working as a freelance writer for the past 3 years



Essentially, cystic fibrosis may be described as an autosomal recessive disease that is caused by defects in the cystic fibrosis trans-membrane conductance regulator (CFTR) gene. When functioning normally, the gene is involved in encoding for a protein that functions as a chloride channel in addition to the regulation of the flow of ions across the apical surface of the epithelial cells.
Mutations of the gene cause abnormalities of camp- regulated chloride transport across the epithelial cells of the mucosal surfaces. As a result of the failure to conduct chloride by the epithelial cells associated with the transport of water, there are abnormalities that result in viscid secretions in the respiratory tract, sweat glands, the gastrointestinal tract as well as other exocrine tissues. As a result of increased viscosity of the secretions, it becomes difficult to clear them. However, how the disease affects an individual is largely dependent on the mutation of the gene. Although cystic fibrosis may affect multiple organ systems, it typically results in chronic respiratory infections, insufficiency of pancreatic enzyme as well as other associated complications among the untreated patients.


The mutations of the CFTR gene bring about abnormalities in camp- regulated chloride transport across the epithelial cells on the mucosal surfaces. Some of the main defects that result from the mutations of this gene include;

  1. The complete absence of CFTR protein synthesis,
  2. A defective maturation of the protein as well s early degeneration - this is caused by the mutation (δf508), which has been shown to be one of the most common mutations,
  3. Disordered regulation - this is where ATP binding is diminished as well as diminished hydrolysis,
  4. Defective conductance of chloride/ channel gating,
  5. Diminished transcription as a result of promoter/splicing abnormalities,
  6. Accelerated channel turnover from the cell surface,

As a result of the defective CFTR, there is reduced secretion of chloride as well as an increased re-absorption of sodium and water across the epithelial cells. This results in a reduced height of the epithelial lining fluid as well as decreased hydration of the mucus, which in turn results in mucus that is stickier to bacteria. This promotes infection and inflammation.


Clinical presentation

The manifestation of cystic fibrosis has been shown to be high changeable, appearing in neonatal period as well as later in life. With some of the patients, the condition is highly asymptomatic for several years. Some of the most common clinical sign of cystic fibrosis include chronic cough, chronic diarrhea as well as malnutrition. Although these are just a few of the major clinical signs, it can appear in various other ways, affecting multiple systems and organs. One of the other most common symptoms that affect the digestive tract is exocrine pancreatic insufficiency. This is typically characterized by chronic diarrhea with the presence of undigested foods. There is also decreased secretion of sodium bicarbonate, which tends to reduce the efficacy of pancreatic enzymes as well as the precipitation of bile salts, which also causes increased acidic pH in the duodenum, resulting in malabsoption.

Poor digestion of fats, proteins and carbohydrates is also observed, these being as a result of the obstruction of pancreatic canauli by the mucous plugs.

For people with cystic fibrosis, malabsorption is caused by pre- epithelial dysfunction. This tends to occur following the rejection of non- hydrolysable nutrients in the lumen. Malnutrition results from inadequate digestion of foods as well as increased energy needs, which among these patients is rarely achieved. On the other hand, diabetes among cystic fibrosis patients is as a result of micro-vascular and other macro-vascular complications that are typically linked to accelerated lung deterioration, which ultimately cause increased death rates. Some of the other common signs include;

  • Low levels of one or more fat- soluble vitamins,
  • Vitamin deficiency,
  • Meconium ileus - this is the obstruction of the terminal ileum by a thick meconium. It is the first signal of pancreatic insufficiency affecting about 15 percent of basis.
  • Patients with gastrointestinal symptoms will exhibit nausea and vomiting among other symptoms such as indigestion,
  • Eosinophilic esophagitis (EOE) among patients between 4 and 15 years old,

Respiratory interventions

For patients with massive haematemesis from esophageal varices, it becomes necessary to revert to the basis of airway, breathing and circulation (ABC). Protecting the airway in this case may call for intubation using esophageal balloon tamponade through the use of a Sengstaken-Blakemore Tube. Although intubation maybe necessary, there is still a debate as to whether or not patients with cystic fibrosis should be intubated and ventilated.

Management and outcome

Complex and multi-systemic involvement of cystic fibrosis treatment and follow up are essential in specialty centers (cystic fibrosis) with multidisciplinary care teams. During the initial confirmation, a patient has to undergo baseline assessment, investigations as well as initial therapy. This is in addition to patient/caretaker education, which includes counseling and instructions concerning techniques used for airway clearance as well as the proper use of equipment.
Treating cystic fibrosis aims to:

  • To maintain lung function as close to normal as possible by controlling respiratory infection as well as clearing mucus from the airways,
  • Administering nutritional therapy - this involves the use of enzyme supplements, multivitamins as well as mineral supplements in order to maintain adequate growth,
  • Management of complications,

At home, mild acute pulmonary exacerbation maybe treated using a number of measures that involve;

  • Increasing the frequency of airway clearance,
  • Using oral antibiotics such as fluroquinolones,
  • Increasing the dose of mucolytic agent dornase alfa,
  • Chest physical therapy and postural drainage,
  • Inhaled bronchodilator treatment,

For the patients with cystic fibrosis, medications used for treatment include; mucolytics, bronchodilators, anti- inflammatory agents, pancreatic enzyme supplements, multivitamins as well as the agents that are devised to potentially reverse abnormalities in chloride transport. According to the pulmonary therapies committee of cystic fibrosis foundation, a long term use of hypertonic saline for patients aged 6 and older is recommended for the purposes of improving functions of the lungs as well as reducing the number of exacerbation. Following treatment using drugs like ivacattor and mannitol, Follow up is meant to determine how treatment is helping the patient or the next course of action. Given that this is a problem of gene mutation, management is necessary to ensure that the patient's symptoms are treated for improved health. Treatment is therefore used to treat gastrointestinal diseases, reduce accumulation of mucus, treat pancreatic disease and hepatonility disease and increase the level of pancreatic enzymes to normal.


    0 of 8192 characters used
    Post Comment

    No comments yet.


    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at:

    Show Details
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the or domains, for performance and efficiency reasons. (Privacy Policy)
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)